SCHEMBL7833286

SCHEMBL7833286

NCCCN1CCC(F)CC1c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CFB P00751 2/20 0.39
SIGMAR1 Q99720 2/20 0.39
CYP2D6 P10635 1/20 0.39
CHRNB2 P17787 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA7 P36544 1/20 0.38
CHRNA4 P43681 1/20 0.38
PRMT3 O60678 1/20 0.34
CARM1 Q86X55 1/20 0.34
PRMT6 Q96LA8 1/20 0.34
PRMT1 Q99873 1/20 0.34
PRMT8 Q9NR22 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9673634 0.80 CHRNB2 (0.53) SIGMAR1CYP2D6CHRNB2CHRNB4CHRNA3
SCHEMBL9673637 0.80 CHRNB2 (0.53) SIGMAR1CYP2D6CHRNB2CHRNB4CHRNA3
SCHEMBL3594198 0.80 CHRNB2 (0.53) SIGMAR1CYP2D6CHRNB2CHRNB4CHRNA3
SCHEMBL22473389 0.78 RIPK1 (0.43) CFBCHRNB2CHRNB4CHRNA3CHRNA7
Hydrochloric Acid SCHEMBL7965310 0.78 CHRNB2 (0.46) CFBSIGMAR1CYP2D6CHRNB2CHRNB4
SCHEMBL9199829 0.78 SIGMAR1 (0.40) SIGMAR1CYP2D6CHRNB2CHRNB4CHRNA3
SCHEMBL5672467 0.76 SIGMAR1 (0.42) SIGMAR1CYP2D6CHRNB2CHRNB4CHRNA3
SCHEMBL23491401 0.75 RIPK1 (0.40) CFBCHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL10409487 0.73 SIGMAR1 (0.39) SIGMAR1CYP2D6
Hydrochloric Acid SCHEMBL3672966 0.73 SIGMAR1 (0.49) SIGMAR1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140876-A1 MORPHOLINONE AND MORPHOLINE DERIVATIVES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2001-10-10 EP disclosed
WO-2000035891-A1 MORPHOLINONE AND MORPHOLINE DERIVATIVES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-06-22 WO disclosed